Pizzuti Dana
Insider CIK 1948238 · CRNX Chief Med and Dev Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-12-01 | 2025-12-03 | 5,000 | — | $0 | 69,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-12-01 | 2025-12-03 | 5,000 | $16.89 | $84.5K | 71,837 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-12-01 | 2025-12-03 | 5,000 | $45.02 | $225.1K | 66,837 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-11-03 | 2025-11-05 | 5,000 | — | $0 | 74,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-11-03 | 2025-11-05 | 100 | $43.27 | $4.3K | 66,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-11-03 | 2025-11-05 | 4,900 | $42.65 | $209.0K | 66,370 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-11-03 | 2025-11-05 | 5,000 | $16.89 | $84.5K | 71,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-10-01 | 2025-10-03 | 5,000 | — | $0 | 79,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-10-01 | 2025-10-03 | 5,000 | $16.89 | $84.5K | 71,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-10-01 | 2025-10-03 | 5,000 | $41.81 | $209.1K | 66,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-09-02 | 2025-09-04 | 5,000 | — | $0 | 84,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-09-02 | 2025-09-04 | 5,000 | $32.10 | $160.5K | 96,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-09-02 | 2025-09-04 | 5,000 | $16.89 | $84.5K | 101,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-08-22 | 2025-08-26 | 30,000 | — | $0 | 89,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-08-22 | 2025-08-26 | 30,000 | $30.43 | $912.9K | 66,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-08-22 | 2025-08-26 | 30,000 | $16.89 | $506.7K | 96,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-08-20 | 2025-08-21 | 6,492 | $29.18 | $189.4K | 66,270 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-03-19 | 2025-03-21 | 127 | $34.83 | $4.4K | 72,233 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-03-19 | 2025-03-21 | 2,388 | $34.17 | $81.6K | 72,360 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-02-20 | 2025-02-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-02-20 | 2025-02-24 | 43,000 | — | $0 | 74,748 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-02-03 | 2025-02-05 | 5,000 | — | $0 | 119,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-02-03 | 2025-02-05 | 5,000 | $39.07 | $195.3K | 31,748 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-02-03 | 2025-02-05 | 5,000 | $16.89 | $84.5K | 36,748 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-01-07 | 2025-01-07 | 2,500 | — | $0 | 18,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-01-07 | 2025-01-07 | 2,500 | $19.64 | $49.1K | 31,748 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2025-01-03 | 2025-01-07 | 15,000 | — | $0 | 124,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-01-03 | 2025-01-07 | 15,000 | $52.09 | $781.4K | 29,248 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2025-01-03 | 2025-01-07 | 15,000 | $16.89 | $253.3K | 44,248 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-10-03 | 2024-10-07 | 14,375 | — | $0 | 139,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-10-03 | 2024-10-07 | 14,375 | $54.63 | $785.3K | 28,507 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-10-03 | 2024-10-07 | 14,375 | $16.89 | $242.8K | 42,882 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-07-03 | 2024-07-05 | 14,375 | — | $0 | 153,417 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-07-03 | 2024-07-05 | 14,375 | $16.89 | $242.8K | 42,882 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-07-03 | 2024-07-05 | 14,375 | $44.87 | $645.0K | 28,507 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-06-24 | 2024-06-25 | 9,500 | — | $0 | 167,792 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-06-24 | 2024-06-25 | 9,500 | $16.89 | $160.5K | 37,286 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-06-24 | 2024-06-25 | 9,500 | $45.73 | $434.4K | 27,786 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-04-15 | 2024-04-17 | 14,375 | — | $0 | 177,292 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-04-15 | 2024-04-17 | 14,375 | $16.89 | $242.8K | 42,161 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-04-15 | 2024-04-17 | 14,375 | $44.47 | $639.3K | 27,786 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-03-20 | 2024-03-22 | 10,000 | — | $0 | 191,667 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-03-20 | 2024-03-22 | 4,375 | — | $0 | 201,667 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-03-20 | 2024-03-22 | 714 | $43.69 | $31.2K | 27,786 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-03-20 | 2024-03-22 | 10,000 | $43.28 | $432.8K | 28,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-03-20 | 2024-03-22 | 10,000 | $16.89 | $168.9K | 38,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-03-20 | 2024-03-22 | 4,375 | $45.89 | $200.8K | 28,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-03-20 | 2024-03-22 | 4,375 | $16.89 | $73.9K | 32,875 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2024-03-18 | 2024-03-20 | 411 | $38.14 | $15.7K | 28,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-03-04 | 2024-03-06 | 87,000 | — | $0 | 87,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-03-04 | 2024-03-06 | 23,000 | — | $0 | 28,911 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-01-03 | 2024-01-04 | 14,375 | — | $0 | 206,042 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-01-03 | 2024-01-04 | 14,375 | $35.00 | $503.1K | 5,911 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-01-03 | 2024-01-04 | 14,375 | $16.89 | $242.8K | 20,286 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2023-12-21 | 2023-12-22 | 9,583 | — | $0 | 220,417 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-12-21 | 2023-12-22 | 9,583 | $34.57 | $331.3K | 5,911 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2023-12-21 | 2023-12-22 | 9,583 | $16.89 | $161.9K | 15,494 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2023-04-05 | 2023-04-05 | 8,212 | $16.15 | $132.6K | 4,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2023-04-03 | 2023-04-05 | 4,288 | $15.98 | $68.5K | 12,712 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-03-01 | 2023-03-03 | 21,000 | — | $0 | 21,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-03-01 | 2023-03-03 | 4,500 | — | $0 | 17,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-10-10 | 2022-10-11 | 230,000 | — | $0 | 230,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2022-10-10 | 2022-10-11 | 12,500 | — | $0 | 12,500 | SEC↗ |